Ibuprofen原料药市场规模、份额和成长分析（按应用、製剂类型和地区划分）－2025-2032年产业预测

世界のIbuprofen原料药市场规模は、2023年に62亿米ドルと评価され、2024年の64亿6,000万米ドルから2032年までに89亿8,000万米ドルへ成长する见込みです。予测期间（2025年～2032年）におけるCAGRは4.2％と予测されています。

由于医疗保健服务可近性的提高、人口老化以及学名药的日益普及，全球Ibuprofen原料药市场正经历显着增长。处方药和非处方药领域对消炎镇痛产品的需求激增，推动了这一成长趋势。推动市场扩张的关键因素包括全球人口老化、医疗保健服务可近性的提高以及消费者对经济实惠的学名药的偏好。北美和欧洲由于对高品质原料药的持续需求而占据了相当大的市场份额，但原材料成本波动和监管壁垒等挑战可能会威胁到业务运营的稳定性。亚太地区的市场前景依然乐观，尤其是在产能和出口量方面处于主导地位，预计这些因素将在近期影响市场趋势。

全球Ibuprofen原料药市场驱动因素

全球Ibuprofen原料药市场正经历显着成长，主要驱动力是消费者对经济实惠的止痛和抗发炎药物日益增长的需求。专利到期和非专利药的出现（受医疗保健可负担性政策的推动）提高了市场可及性。此外，人口老化以及慢性疼痛和发炎相关疾病盛行率的上升进一步加速了市场扩张，提升了市场规模和收入潜力。这些因素共同为全球Ibuprofen原料药产品的成长与发展创造了强劲的环境。

全球Ibuprofen原料药市场面临的限制因素

全球Ibuprofen活性原料药市场面临许多挑战，其中关键前驱物（如异丁基苯和乙酰氯）价格的波动尤为显着。这些价格波动会直接影响生产成本和整体盈利，尤其对中小型生产者而言更是如此。此外，对少数供应商的依赖加剧了供应链风险，导致市场环境难以预测且波动剧烈。这种依赖性使得企业难以製定计画和进行预测，难以应对不断变化的市场环境，也难以在外部压力下维持稳定的营运效率。

全球Ibuprofen原料药市场趋势

全球Ibuprofen原料药市场正呈现日益明显的地域多角化和近岸外包趋势，买家寻求降低供应链风险。这项转变正在亚太地区打造新的市场格局，中小型製造商纷纷涌现，以提升产能和市场渗透率。同时，在对供应安全和可靠性日益重视的推动下，北美和欧洲的需求也显着復苏。这种双管齐下的策略不仅促进了价格竞争和创新，还在Ibuprofen原料药产业建构了更具韧性的供应链框架，重塑了全球贸易动态。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2024）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

Ibuprofen原料药市场规模（按应用及复合年增长率划分）（2025-2032 年）

• 市场概览
• 製药
• 消费者医疗保健
• 动物保健

Ibuprofen原料药市场规模（按製剂类型和复合年增长率划分）（2025-2032 年）

• 市场概览
• 药片
• 口服
• 暂停
• 外用药物

Ibuprofen原料药市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2024 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2024 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2022-2024年营收年比比较

主要企业简介

• BASF SE（Germany）
• IOL Chemicals and Pharmaceuticals Limited（IOLCP）（India）
• Shandong Xinhua Pharmaceutical Co., Ltd.（China）
• Solara Active Pharma Sciences Limited（India）
• SI Group, Inc.（United States）
• Dr. Reddy's Laboratories Ltd.（India）
• Granules India Limited（India）
• Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd.（China）
• Strides Pharma Science Limited（India）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Pfizer Inc.（United States）
• Abbott Laboratories（United States）
• BIOCAUSE Inc.（United States）
• Mallinckrodt Pharmaceuticals（United States）
• SMS Pharmaceuticals Ltd.（India）
• Wanbury Limited（India）
• Aurobindo Pharma Ltd.（India）
• Zhejiang Huahai Pharmaceutical Co., Ltd.（China）
• Jubilant Life Sciences Ltd.（India）
• Sun Pharmaceutical Industries Ltd.（India）

结论与建议

Global Ibuprofen API Market size was valued at USD 6.2 billion in 2023 and is poised to grow from USD 6.46 billion in 2024 to USD 8.98 billion by 2032, growing at a CAGR of 4.2% during the forecast period (2025-2032).

The global Ibuprofen API market is experiencing notable growth driven by increased healthcare access, an aging demographic, and the widespread adoption of generic medications. A surge in demand for anti-inflammatory and analgesic products across both prescription and over-the-counter sectors contributes to this upward trend. Key factors fueling this expansion include the global aging population, enhanced healthcare accessibility, and a preference for cost-effective generic options. North America and Europe hold substantial market shares due to sustained interest in premium APIs, although challenges such as fluctuating raw material costs and regulatory hurdles may threaten operational consistency. The outlook remains optimistic, particularly in the Asia Pacific region, which is poised to lead in production capacity and export volume, influencing market trends in the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ibuprofen API market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ibuprofen API Market Segments Analysis

Global Ibuprofen API Market is segmented by Application, Formulation Type and region. Based on Application, the market is segmented into Pharmaceuticals, Consumer Healthcare and Animal Healthcare. Based on Formulation Type, the market is segmented into Tablets, Oral, Suspension and Topical. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Ibuprofen API Market

The Global Ibuprofen API market is experiencing significant growth, primarily fueled by the rising demand for cost-effective pain relief and anti-inflammatory drugs. The emergence of generic formulations, facilitated by the expiration of patents and efforts to make healthcare more affordable, bolsters market accessibility. Additionally, an aging population and a higher prevalence of chronic pain conditions and inflammation-related disorders further drive the expansion of this market, enhancing both its size and revenue potential. Overall, these factors combine to create a robust environment for the growth and development of Ibuprofen API products worldwide.

Restraints in the Global Ibuprofen API Market

The Global Ibuprofen API market faces significant challenges due to fluctuations in the prices of essential precursors, such as isobutyl benzene and acetyl chloride. These price variations can directly impact production costs and overall profitability, particularly for small- and medium-sized manufacturers. Additionally, the reliance on a limited number of suppliers heightens the exposure to supply chain risks, leading to an unpredictable and unstable market environment. This dependence complicates planning and forecasting efforts, making it difficult for businesses to navigate the evolving landscape and maintain consistent operational efficiency in the face of these external pressures.

Market Trends of the Global Ibuprofen API Market

The Global Ibuprofen API market is witnessing a progressive trend of regional diversification and near-shoring as buyers aim to mitigate supply chain risks. This shift is leading to an evolving market landscape where smaller to mid-sized manufacturers are emerging in the Asia-Pacific region, enhancing production capabilities and market penetration. Concurrently, there is a noticeable resurgence of demand in North America and Europe, driven by a growing emphasis on supply security and reliability. This dual approach not only fosters competitive pricing and innovation but also establishes a more resilient supply chain framework within the ibuprofen API sector, reshaping global trade dynamics.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Ibuprofen API Market Size by Application & CAGR (2025-2032)

• Market Overview
• Pharmaceuticals
• Consumer Healthcare
• Animal Healthcare

Global Ibuprofen API Market Size by Formulation Type & CAGR (2025-2032)

• Market Overview
• Tablets
• Oral
• Suspension
• Topical

Global Ibuprofen API Market Size & CAGR (2025-2032)

• North America (Application, Formulation Type)
  • US
  • Canada
• Europe (Application, Formulation Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Application, Formulation Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Application, Formulation Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Application, Formulation Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• BASF SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IOL Chemicals and Pharmaceuticals Limited (IOLCP) (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shandong Xinhua Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Solara Active Pharma Sciences Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SI Group, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Granules India Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Strides Pharma Science Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOCAUSE Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt Pharmaceuticals (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SMS Pharmaceuticals Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wanbury Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurobindo Pharma Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zhejiang Huahai Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jubilant Life Sciences Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations